Relay Therapeutics up AGAIN today
This stock keeps climbing.. The combination of a Phase 3 breast cancer trial underway, a potential accelerated approval path in vascular anomalies, FDA Breakthrough status, and two years of cash is a pretty compelling setup for a clinical-stage biotech. Every …